RTA confirms no demat or remat requests in Q2 FY27

Compliance View source PDF Explain this filing

SAIPARENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹519.05

prior close

₹498.30

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%-0.5% vs market

Pharmaceuticals peers, median of 172sector-2.4%-0.8% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

+0.1

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3-2.8-0.5-2.4-0.8

Next day

-4.6-2.5-2.1-2.6-2.1

-2.9-1.7-1.2-2.5-0.4

-4.2-1.5-2.7-2.5-1.7

-4.3-0.8-3.5-2.5-1.8

-6.9-2.4-4.5-3.2-3.8

-7.0-3.4-3.6-4.3-2.7

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Parenterals filed the quarterly compliance certificate from its Registrar and Transfer Agent, Bigshare Services, for the quarter ended 30 September 2026 under SEBI regulation 74(5). The RTA confirmed that the entire shareholding of the company is already held in demat form, making the regulation inapplicable, and no requests for dematerialization or rematerialization were received during the quarter. This is a routine procedural compliance filing with no bearing on the business or shareholders.

Likely market impact

Routine procedural filing with no impact on shareholders or share price.